Eli Lilly (LLY): FY24 Q4 earnings call, Feb 6, 2025

Thu, Feb 6Earnings callSpeaker-labelled transcriptEli Lilly

No Kalshi or Polymarket word markets were listed for Eli Lilly’s Feb 6, 2025 earnings call (FY24 Q4). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

3 matches for “Vial”; 2 quoted, at least 25 words apart.

David Rickscompanyprepared

…'23. With more patients using Lilly Direct, the uptake of single-use Zepbound vials increased. We had no wholesaler back orders as we closed 2024, and…

Alexandria Hammondanalystqa

…this relationship evolving? And a follow-up, can you help frame the opportunity associated with Zepbound vials? And how is that expected to shift over time?

Agents: this page as TSV at /api/v1/appearances/eli-lilly:2025-02-06:earnings_call · words: /api/v1/brief?appearance=eli-lilly:2025-02-06:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP